美國Ariad Pharmaceuticals
Ariad Pharmaceuticals公司是一家生物制藥公司,在美國和歐洲專注于發明、開發和銷售推廣用于治和療癌癥的小分子藥物。它的產品包括deforolimus、AP24534。另外,該公司許可NF - kB的細胞信號技術和治療方法、ARGENT細胞信號調節技術,并與Medinol和ICON達成許可協議。該公司成立于1991年,設在美國馬薩諸塞州的劍橋,擁有150名全職員工。
ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.